The Utility of Delta-9-Tetrahydrocannibinol Therapy in a Multiple Sclerosis Patient with a Neoplastic Brain Lesion
  • Aurora Fuiani
    Department of Neuroscience, Riuniti Hospital of Foggia, Foggia, Italy

Keywords

Multiple sclerosis, delta-9-tetrahydrocannabinol, brain tumour, epileptic seizure

Abstract

Multiple sclerosis (MS) can sometimes cause uncommon pseudotumoural lesions that produce atypical symptoms, such as motor epileptic seizures which are often pharmacoresistant. In these cases, accurate diagnosis is essential for correct therapy, even if unconventional. We present the case of a brain tumour in a 40-year-old relapsing-remitting MS patient who presented with pharmacoresistant seizures which eventually responded to nabiximols. After various therapeutic approaches, delta-9-tetrahydrocannabinol therapy was introduced with good results. Spasticity improved, pain decreased and we observed a reduction in the number of daily seizures. It is possible that delta-9-tetrahydrocannabinol can enhance the efficacy of anti-epilepsy therapy.

VIEW THE ENTIRE ARTICLE

References

  • Consroe P, Wolkin A. Cannabidiol: antiepileptic drug comparisons and interactions experimentally induced seizures in rats. J Pharmacol Exp Ther 1977;201:26–32.
  • Mathern G, Nehlig A, Sperling M. Cannabidiol and medical marijuana for the treatment of epilepsy. Epilepsia 2014;55:781–782.
  • Ware M, Wang T, Shapiro S, Collet JP. Cannabis for the management of pain: assessment of safety study (COMPASS). J Pain 2015;16(12):1233–1242.
  • Silva GD, Del Guerra FB, De Oliveira Lelis M, Figueira Pinto L. Cannabidiol in the treatment of epilepsy: a focused review of evidence and gaps. Front Neurol 2020;11:531939.
  • Morgan C, Freeman TM, Hindocha C, Schafer G, Gardner C. Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function. Transl Psychiatry 2018;8:181.
  • Wang GS, Bourne D, Klawitter J, Sempio C, Chapman K, Knupp K, at al. Disposition of oral delta-9 tetrahydrocannabinol (THC) in children receiving cannabis extracts for epilepsy. Clin Toxicol (Phila) 2020;58(2):124–128.

    • Views: 578
    HTML downloads: 56
    PDF downloads: 437

    Published: 2021-05-03
    Issue: 2021: Vol 8 No 5 (view)

    How to cite:
    1.
    Fuiani A. The Utility of Delta-9-Tetrahydrocannibinol Therapy in a Multiple Sclerosis Patient with a Neoplastic Brain Lesion . EJCRIM 2021;8 doi:10.12890/2021_002188.